208 related articles for article (PubMed ID: 15769459)
1. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.
Schoneveld AH; Oude Nijhuis MM; van Middelaar B; Laman JD; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2005 Apr; 66(1):162-9. PubMed ID: 15769459
[TBL] [Abstract][Full Text] [Related]
2. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.
Bieneman AP; Chichester KL; Chen YH; Schroeder JT
J Allergy Clin Immunol; 2005 Feb; 115(2):295-301. PubMed ID: 15696084
[TBL] [Abstract][Full Text] [Related]
4. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells.
Shuang Chen ; Wong MH; Schulte DJ; Arditi M; Michelsen KS
J Endotoxin Res; 2007; 13(5):281-96. PubMed ID: 17986487
[TBL] [Abstract][Full Text] [Related]
6. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta down-regulates IL-1alpha-induced TLR2 expression in murine hepatocytes.
Matsumura T; Hayashi H; Takii T; Thorn CF; Whitehead AS; Inoue J; Onozaki K
J Leukoc Biol; 2004 Jun; 75(6):1056-61. PubMed ID: 15039464
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 is involved in outward arterial remodeling.
Hollestelle SC; De Vries MR; Van Keulen JK; Schoneveld AH; Vink A; Strijder CF; Van Middelaar BJ; Pasterkamp G; Quax PH; De Kleijn DP
Circulation; 2004 Jan; 109(3):393-8. PubMed ID: 14699006
[TBL] [Abstract][Full Text] [Related]
10. Cultured astrocytes express toll-like receptors for bacterial products.
Bowman CC; Rasley A; Tranguch SL; Marriott I
Glia; 2003 Sep; 43(3):281-91. PubMed ID: 12898707
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
12. Heat shock up-regulates expression of Toll-like receptor-2 and Toll-like receptor-4 in human monocytes via p38 kinase signal pathway.
Zhou J; An H; Xu H; Liu S; Cao X
Immunology; 2005 Apr; 114(4):522-30. PubMed ID: 15804289
[TBL] [Abstract][Full Text] [Related]
13. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions.
Vink A; Schoneveld AH; van der Meer JJ; van Middelaar BJ; Sluijter JP; Smeets MB; Quax PH; Lim SK; Borst C; Pasterkamp G; de Kleijn DP
Circulation; 2002 Oct; 106(15):1985-90. PubMed ID: 12370224
[TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.
Kobayashi M; Yoshiki R; Sakabe J; Kabashima K; Nakamura M; Tokura Y
Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710
[TBL] [Abstract][Full Text] [Related]
16. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury.
Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I
Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.
Jung YO; Cho ML; Kang CM; Jhun JY; Park JS; Oh HJ; Min JK; Park SH; Kim HY
Immunol Lett; 2007 Mar; 109(1):21-7. PubMed ID: 17289161
[TBL] [Abstract][Full Text] [Related]
19. Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA.
Di Genaro MS; Cargnelutti DE; Castro DO; Eliçabe RJ; Gutiérrez JV; Correa SG; de Guzmán AM
Scand J Rheumatol; 2007; 36(1):28-35. PubMed ID: 17454932
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
